182 related articles for article (PubMed ID: 37455204)
1. Gene therapy and other novel treatment approaches for Charcot-Marie-Tooth disease.
Pisciotta C; Pareyson D
Neuromuscul Disord; 2023 Aug; 33(8):627-635. PubMed ID: 37455204
[TBL] [Abstract][Full Text] [Related]
2. Challenges in Treating Charcot-Marie-Tooth Disease and Related Neuropathies: Current Management and Future Perspectives.
Pisciotta C; Saveri P; Pareyson D
Brain Sci; 2021 Oct; 11(11):. PubMed ID: 34827446
[TBL] [Abstract][Full Text] [Related]
3. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
4. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
5. Updated review of therapeutic strategies for Charcot-Marie-Tooth disease and related neuropathies.
Pisciotta C; Saveri P; Pareyson D
Expert Rev Neurother; 2021 Jun; 21(6):701-713. PubMed ID: 34033725
[No Abstract] [Full Text] [Related]
6. Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A).
Prukop T; Stenzel J; Wernick S; Kungl T; Mroczek M; Adam J; Ewers D; Nabirotchkin S; Nave KA; Hajj R; Cohen D; Sereda MW
PLoS One; 2019; 14(1):e0209752. PubMed ID: 30650121
[TBL] [Abstract][Full Text] [Related]
7. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
[TBL] [Abstract][Full Text] [Related]
8. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
[TBL] [Abstract][Full Text] [Related]
9. Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice.
Bai Y; Treins C; Volpi VG; Scapin C; Ferri C; Mastrangelo R; Touvier T; Florio F; Bianchi F; Del Carro U; Baas FF; Wang D; Miniou P; Guedat P; Shy ME; D'Antonio M
Mol Neurobiol; 2022 Jul; 59(7):4159-4178. PubMed ID: 35501630
[TBL] [Abstract][Full Text] [Related]
10. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
Chumakov I; Milet A; Cholet N; Primas G; Boucard A; Pereira Y; Graudens E; Mandel J; Laffaire J; Foucquier J; Glibert F; Bertrand V; Nave KA; Sereda MW; Vial E; Guedj M; Hajj R; Nabirotchkin S; Cohen D
Orphanet J Rare Dis; 2014 Dec; 9():201. PubMed ID: 25491744
[TBL] [Abstract][Full Text] [Related]
11. Natural history and treatment of peripheral inherited neuropathies.
Pareyson D; Marchesi C
Adv Exp Med Biol; 2009; 652():207-24. PubMed ID: 20225028
[TBL] [Abstract][Full Text] [Related]
12. Mutation analysis of MFN2, GJB1, MPZ and PMP22 in Italian patients with axonal Charcot-Marie-Tooth disease.
Bergamin G; Boaretto F; Briani C; Pegoraro E; Cacciavillani M; Martinuzzi A; Muglia M; Vettori A; Vazza G; Mostacciuolo ML
Neuromolecular Med; 2014 Sep; 16(3):540-50. PubMed ID: 24819634
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy approaches targeting Schwann cells for demyelinating neuropathies.
Sargiannidou I; Kagiava A; Kleopa KA
Brain Res; 2020 Feb; 1728():146572. PubMed ID: 31790684
[TBL] [Abstract][Full Text] [Related]
14. Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) rats.
Prukop T; Wernick S; Boussicault L; Ewers D; Jäger K; Adam J; Winter L; Quintes S; Linhoff L; Barrantes-Freer A; Bartl M; Czesnik D; Zschüntzsch J; Schmidt J; Primas G; Laffaire J; Rinaudo P; Brureau A; Nabirotchkin S; Schwab MH; Nave KA; Hajj R; Cohen D; Sereda MW
J Neurosci Res; 2020 Oct; 98(10):1933-1952. PubMed ID: 32588471
[TBL] [Abstract][Full Text] [Related]
15. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice.
Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R
Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559
[TBL] [Abstract][Full Text] [Related]
16. Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies.
Stavrou M; Sargiannidou I; Georgiou E; Kagiava A; Kleopa KA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205075
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic yield of targeted sequential and massive panel approaches for inherited neuropathies.
Padilha JPD; Brasil CS; Hoefel AML; Winckler PB; Donis KC; Brusius-Facchin AC; Saute JAM
Clin Genet; 2020 Aug; 98(2):185-190. PubMed ID: 32506583
[TBL] [Abstract][Full Text] [Related]
18. The Current State of Charcot-Marie-Tooth Disease Treatment.
Okamoto Y; Takashima H
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510296
[TBL] [Abstract][Full Text] [Related]
19. Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene.
Sanmaneechai O; Feely S; Scherer SS; Herrmann DN; Burns J; Muntoni F; Li J; Siskind CE; Day JW; Laura M; Sumner CJ; Lloyd TE; Ramchandren S; Shy RR; Grider T; Bacon C; Finkel RS; Yum SW; Moroni I; Piscosquito G; Pareyson D; Reilly MM; Shy ME;
Brain; 2015 Nov; 138(Pt 11):3180-92. PubMed ID: 26310628
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
Bort S; Nelis E; Timmerman V; Sevilla T; Cruz-Martínez A; Martínez F; Millán JM; Arpa J; Vílchez JJ; Prieto F; Van Broeckhoven C; Palau F
Hum Genet; 1997 Jun; 99(6):746-54. PubMed ID: 9187667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
